Success Story: NIW Approved Smoothly Without an RFE for an Indian Research Scientist
Client’s Testimonial:
“Thanks so much for your help.”
On March 11th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Research Scientist
Country of Origin: India
State of Residence at the Time of Filing: California
Approval Notice Date: March 11th, 2025
Processing Time: 15 months, 18 days
Case Summary:
We are pleased to share the success story of an EB-2 NIW (National Interest Waiver) approval granted to a biomedical science expert whose research is advancing our understanding of immune responses to infectious diseases. At the time of filing, the client held a Ph.D. in medicine and was engaged in research focusing on immunological mechanisms that govern the body’s defense against viral infections associated with cancer development.
Research with Substantial Merit and National Importance:
The client’s proposed endeavor aims to investigate how human tonsillar immune cells respond to infections such as the Kaposi Sarcoma herpesvirus (KSHV), with the ultimate goal of contributing to the development of therapeutic interventions and vaccines that can prevent the progression of such infections to cancer. This research is of clear national importance, as it supports efforts to combat cancer-linked viruses and reduce the public health burden of virus-associated malignancies. The client’s work has direct implications for immunotherapy design, vaccine development, and cancer prevention – core priorities in both public health and biomedical research sectors.
Well Positioned to Advance the Proposed Endeavor:
The client has demonstrated a clear and consistent record of productivity and impact in the field of biomedical science. His body of work includes 11 peer-reviewed journal articles, 6 of which are first-authored, as well as 1 preprint. These publications have been cited 357 times according to Google Scholar, underscoring the recognition and influence of his research among peers. Furthermore, the client has completed at least 7 peer reviews for scientific journals, further confirming his expertise and standing in the academic community. His training and publication record reflect not only a high level of technical skill but also a sustained commitment to advancing biomedical knowledge that can lead to tangible health benefits.
NIW Approval and Outlook:
This I-140 NIW petition was filed in November 2023 and approved in March 2025. The successful outcome reflects both the national relevance of the client’s proposed endeavor and his exceptional qualifications to carry it forward. NAILG is honored to have played a role in securing this approval and looks forward to the continued impact of this promising scientist’s work in the field of immunology and infectious disease prevention.